JP Patent

JP7644027B2 — Ｂｔｋ阻害剤の結晶形態

Assigned to ノバルティスアーゲー · Expires 2025-03-11 · 1y expired

What this patent protects

Patent listed against Akynzeo.

Drugs covered by this patent

Akynzeo (NETUPITANT) · Helsinn Hlthcare

Patent Metadata

Patent number: JP7644027B2
Jurisdiction: JP
Classification: —
Expires: 2025-03-11
Drug substance claim: No
Drug product claim: No
Assignee: ノバルティスアーゲー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.